RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 65.20
-0.95 (-1.44%)
Jul 23, 2025, 1:45 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 39.93 billion as of July 22, 2025. Its market cap has increased by 79.37% in one year.
Market Cap
39.93B
Enterprise Value
42.09B
Revenue
2.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
65.20
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 39.93B, an increase of 19.60%. That is a compound annual growth rate of 3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2025 | 39.93B | 185.14% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 274.26B |
| Hansoh Pharmaceutical Group Company | 214.35B |
| JD Health International | 152.65B |
| Innovent Biologics | 152.22B |
| Akeso | 126.29B |
| Sino Biopharmaceutical | 123.40B |
| WuXi Biologics | 116.17B |
| CSPC Pharmaceutical Group | 105.04B |